An evolving perspective on novel modified release drug delivery systems for inhalational therapy

Tanvirul Hye; Sakib  M Moinuddin; Tanoy Sarkar; Trieu Nguyen; Dipongkor Saha; Fakhrul Ahsan

An evolving perspective on novel modified release drug delivery systems for inhalational therapy

Tanvirul Hye
, Sakib M Moinuddin
, Tanoy Sarkar
, Trieu Nguyen
, Dipongkor Saha
, Fakhrul Ahsan

Biology

Research output: Contribution to journal › Review article

Abstract

Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases such as pulmonary hypertension. To treat respiratory diseases, targeted, modified or controlled release inhalation formulations are desirable for improved patient compliance and superior therapeutic outcome.

Original language	English
Pages (from-to)	335-348
Journal	Expert opinion on drug delivery
Volume	20
Issue number	3
State	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{693d504926ef4635b767a308f6b2460e,

title = "An evolving perspective on novel modified release drug delivery systems for inhalational therapy",

abstract = "Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases such as pulmonary hypertension. To treat respiratory diseases, targeted, modified or controlled release inhalation formulations are desirable for improved patient compliance and superior therapeutic outcome.",

author = "Tanvirul Hye and Moinuddin, \{Sakib M\} and Tanoy Sarkar and Trieu Nguyen and Dipongkor Saha and Fakhrul Ahsan",

year = "2023",

language = "English",

volume = "20",

pages = "335--348",

journal = "Expert opinion on drug delivery",

number = "3",

}

TY - JOUR

T1 - An evolving perspective on novel modified release drug delivery systems for inhalational therapy

AU - Hye, Tanvirul

AU - Moinuddin, Sakib M

AU - Sarkar, Tanoy

AU - Nguyen, Trieu

AU - Saha, Dipongkor

AU - Ahsan, Fakhrul

PY - 2023

Y1 - 2023

N2 - Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases such as pulmonary hypertension. To treat respiratory diseases, targeted, modified or controlled release inhalation formulations are desirable for improved patient compliance and superior therapeutic outcome.

AB - Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases such as pulmonary hypertension. To treat respiratory diseases, targeted, modified or controlled release inhalation formulations are desirable for improved patient compliance and superior therapeutic outcome.

M3 - Review article

VL - 20

SP - 335

EP - 348

JO - Expert opinion on drug delivery

JF - Expert opinion on drug delivery

IS - 3

ER -

An evolving perspective on novel modified release drug delivery systems for inhalational therapy

Abstract

UN SDGs

Fingerprint

Cite this